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Sex Differences in Release of Cardiac Troponin T after Endurance Exercise 
 
Abstract 
CONTEXT: Post-exercise cardiac troponin release has been extensively described in 
athletic groups but little attention has been given to any role of sex in mediating this 
phenomenon. OBJECTIVE: We compared the release of cardiac troponin T (cTnT) 
after endurance running in training-experience, biological-age and maturity-matched 
young male and female runners. MATERIALS AND METHODS: Nineteen male 
(training history: 2.3±1.0 yr; mean age: 16.1±1.2 yr; Tanner stage: 3.7±0.6) and 19 
female (training history: 2.2±1.0 yr; mean age: 15.9±1.4 yr; Tanner stage: 4.0±0.4) 
runners performed a 21 km run with “all-out” effort. Serum cTnT levels were assessed 
at pre-exercise (Pre-ex) and at 4 h post-exercise (Post-ex). RESULTS: At Pre-ex, cTnT 
concentrations were below the 99th percentile value (10 ng.l-1) in 32/38 runners. Post-
ex cTnT increased in all subjects but the response was substantially higher (P<0.05) in 
males [median (range): 210 (20–1360) ng.l-1] than females [median (range): 80 (10–
550) ng.l-1]. At Post-ex, 95% (95% confidence interval: 75-99%) of males and 63% 
(95% confidence interval: 41-81%) of females (P<0.05) had cTnT concentrations above 
the cut-off for acute myocardial infarction. CONCLUSIONS: The present data suggest 
that post-exercise cTnT elevation occurs in all runners but is augmented in young male 
compared to female athletes. 
 
Keywords: cardiac biomarker, adolescents, sex, endurance exercise 
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Introduction 
A growing body of evidence suggests that prolonged, strenuous exercise may result in 
the appearance of cardiac troponins (cTnT and cTnI) (Shave et al., 2010) which are 
highly specific biomarkers of cardiomyocyte insult (Wu et al., 1999). To date, however, 
there has been no consensus as to the performance impact or clinical relevance of such 
findings (Shave et al., 2010). An important part of exploring this biomarker response 
to exercise is understanding factors that may be associated with the presence and 
amplitude of the elevation in cTn. The information may be useful for clinicians and the 
challenging interpretation of elevated cTn levels in athletes. 
Although we (Tian et al., 2012) (Nie et al., 2011b) (Nie et al., 2011a) (Fu et al., 
2009) and others (Eijsvogels et al., 2015) (Mehta et al., 2012) (Sahlen et al., 2009) have 
demonstrated that subject characteristics (i.e. age and training experience), exercise 
characteristics (i.e. exercise duration and intensity) and environmental strain may relate 
to the exercise-induced increase in cTn, the magnitude of exercise-induced cTn release 
can only be partially explained by such parameters (Eijsvogels et al., 2015). Further 
research into personal or exercise characteristics associated with exercise-related values 
of cTn is required.  
The observation of a lower release of creatine kinase from skeletal muscle cells 
in women compared to men after strenuous exercise suggests that women may be more 
protected against skeletal muscle damage (Enns and Tiidus, 2010). Whether sex imbues 
any protective effect in the face of cardiomyocyte insult after exercise is not known. 
There is evidence that better haemodynamic preservation and reduced cellular injury is 
observed in female piglets after resuscitation from clinically relevant haemorrhage and 
circulatory arrest (Semenas et al., 2010). In human clinical work, men had markedly 
higher serum cTnI than women after cardiac surgery suggesting a sex-based difference 
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in the cellular damage associated with ischemia-reperfusion (Schwarzenberger et al., 
2003).   
To the best of our knowledge, only one study has reported cTn in male and 
female runners after prolonged exercise and they reported no sex-based differences 
(Traiperm et al., 2012). This study did not match athletes for training experience and 
age that have been identified as important factors that influence exercise-induced cTn 
release (Nie et al., 2011a) (Tian et al., 2012) (Mehta et al., 2012) (Sahlen et al., 2009).  
Consequently this topic requires further controlled evaluation.  
The aim of the present study was to determine sex-related differences in the 
cTnT response to exercise in young male and female athletes matched for training 
experience, biological age and sexual maturity. The study of younger athletes reduces 
any potential confounding effects of ageing and associated cardiac pathologies (Eggers 
et al., 2008). We hypothesize that the magnitude of cTnT responses to prolonged 
exercise will be significantly higher in young male compared to female athletes. 
 
Materials and Methods 
Subjects 
A total of 45 male and 29 female adolescent endurance runners, performing at a national 
level and training professionally in running clubs in China, were invited to participate 
in the experiment. Nineteen male and 19 female runners were selected having been 
matched for biological age, sexual maturity and training experience (all P>0.05). 
Maturational status was evaluated by self-assessment of the genitalia and pubic hair 
stage and a Tanner stage assigned (Tanner, 1981) using a previously validated procedure 
(Duke et al., 1980). None of the subjects had any clinical evidence or personal history 
of cardiac disease or arterial hypertension as assessed by a cardiologist (Siddiqui and 
Patel, 2010). All procedures conformed to the Declaration of Helsinki and were 
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approved by the Local Ethics Committee. Written informed consent was obtained from 
all the subjects as well as parents or legal guardians in the case of adolescents. 
 
Design, Procedures and Measurements 
All the adolescents participated in a simulated half-marathon running race, performing 
the 21 km run at their own maximal sustainable pace with “all-out” effort on a standard 
400 m track where the ambient temperature and relative humidity ranged from 5 to 
10 °C and 30 to 50 %, respectively. All the trials were scheduled in the morning from 
8:00 to 10:00 in order to fit in with the subjects’ routine training schedules, and were 
carried out on three different days, with 10–14 subjects (same number of males and 
females) running together on each day. The performance times were recorded. Testing 
occurred during the “pre-season” training period. The training volume of the subjects 
was 60–70 km.week-1, 6–21 km.day-1 for 6–7 days.week-1. The subjects refrained from 
eating for at least 2 h and from participating in strenuous physical activity for at least 
24 h before the 21 km run.  
The first blood sample was collected at rest (Pre-ex) prior to the 21-km running 
test. Immediately following this, the subjects performed the 21 km run, with a second 
blood sample (Post-ex) being taken 4 h after completion of the run. The timing for the 
post-exercise blood sample was in accordance with our previous work that 
demonstrated that serum cTnT concentrations peaked 4 h after competition of a 21 km 
run (Nie et al., 2011c) and a laboratory-based 90 min run (Tian et al., 2012) by 
employing multiple sampling points among similar adolescent runners of a similar 
fitness level. At both sampling times, 2 ml of venous blood was drawn from the 
antecubital vein with subjects in a sitting position. The blood was allowed to clot at 
room temperature and then centrifuged at 2,000 g for 20 min. The separated serum was 
stored at –20 °C for later analyses.  
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For analysis of serum cTnT, a third-generation assay was performed using an 
electrochemiluminescence technology employed by the Elecsys 2010 automated batch 
analyzer (Roche Diagnostics, Basel, Switzerland). The inter-assay coefficient of 
variation was 10% at 30 ng.l-1 and 3% at 100 ng.l-1. The intra-assay coefficient of 
variation was 8% at 30 ng.l-1 and 2% at 100 ng.l-1, with a detection limit of 10 ng.l-1 
(which coincides with the 99th percentile value) and an upper limit of 25000 ng.l-1. 
Serum cTnT levels that were below the limit of detection (< 10 ng.l-1) are reported as 5 
ng.l-1 (Fu et al., 2009, Nie et al., 2011c). The cut-off value for acute myocardial 
infarction (AMI) for serum cTnT is 50 ng.l-1 (Collinson et al., 2003). This value based 
on an international multicentre clinical evaluation of the third-generation cTnT assay 
through construction of receiver operating characteristic curves. (Collinson et al., 2003).  
At rest prior to the 21-km running test, the basic echocardiographic data was 
also collected using an ultrasound system (GE LOGIQ Book XP; GE Healthcare, San 
Jose, CA) according to the American Society of Echocardiography (ASE) guidelines 
(Lang et al., 2015). In brief, cardiac structure was evaluated from parasternal long-axis 
two-dimensional recordings, and left ventricular mass was calculated using the ASE 
formula and indexed according to body surface area. Left ventricular volume and 
ejection fraction (EF) (%) were evaluated with Simpson’s biplane method. 
In addition, follow-up was performed by a cardiologist for each runner at one 
day, 6 months and 13 months after the experiment to exclude the possibility of clinical 
signs or symptoms indicative of cardiac events during the follow-up period. 
 
 
Statistical Analyses 
The Kolmogorov–Smirnov test was used to evaluate the normality of the data. Group 
differences between males and females in physical and training characteristics, and 
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echocardiographic indices were analysed by independent t-tests. The non-parametric 
Wilcoxon signed-rank test was used to compare the cTnT data across the time points 
(Pre-ex and Post-ex) because of a skewed distribution. Concentrations of cTnT in males 
and females were compared using the Mann-Whitney U test. The percentage of subjects 
with cTnT exceeding the AMI cut-off criterion of 50 ng.l-1 and the 99th percentile value 
of 10 ng.l-1 at each assessment point were compared using Fisher’s exact test. 
Correlations between post-exercise cTnT and cardiac echocardiographic variables were 
determined via a Pearson product–moment correlation analysis. Statistical significance 
was assumed at a level of P<0.05. Data analysis was performed using the statistical 
software package SPSS 11.5 (SPSS Inc., Chicago, Illinois, USA). 
 
Results 
The physical characteristics of the subjects and their training background are shown in 
Table 1. Although height and body weight was higher in males than females (P<0.05), 
training volume, biological age and Tanner stage were not different (P>0.05) between 
the two groups (Table 1).  
All subjects completed the 21 km run and none of runners had any clinical signs 
or symptoms indicative of myocardial ischemia either during or after exercise. During 
the 21 km run, the mean running time in males (81.7 ± 6.5 min) was shorter than that 
in females (93.8 ± 8.7 min; P<0.05) (Table 1).  
Data for cTnT in male and female runners before and after the 21 km run are 
presented in Table 2 and Figure 1. At Pre-ex, cTnT levels in most subjects (32/38) were 
below the 99th percentile value (10 ng.l-1) and data were not different between two 
groups. cTnT increased Post-ex in all subjects but the median cTnT data were 
significantly higher in male compared to female athletes (P<0.05) (Figure 1). In 
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addition, 95% (95% confidence interval: 75-99%) of males and 63% (95% confidence 
interval: 41-81%) of females (P<0.05) presented with cTnT data above the cut off for 
AMI (50 ng.l-1).  
 
****Table 1, Table 2 and Figure 1 near here**** 
Basic echocardiographic data are presented in Table 3. Male athletes presented 
with higher left ventricular internal diameter at end diastole, left ventricular posterior 
free wall at end diastole, end-diastolic left ventricular volume and left ventricular mass 
(P<0.05). There were, however, no significant correlations (P>0.05) between post-
exercise cTnT levels and cardiac morphologies.  
 
****Table 3 near here**** 
Further, all runners continued their routine training and long-distance run races 
for more than one year after the experiment, and none had any clinical signs or 
symptoms indicative of cardiac events during the follow-up period. 
 
Discussion  
This is the first study to demonstrate that the magnitude of the cTnT responses to 
endurance exercise was significantly higher in young male compared to female athletes. 
Of note was the fact that all subjects had an elevated Post-ex cTnT compared to the Pre-
ex assessment. 
 
Sex-differences in cTnT appearance with prolonged exercise 
The reduced cTnT at 4 h Post-ex in young female athletes compared to biological-age, 
sexual maturity and training experience-matched young male athletes is a new finding 
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that contradicts the only previous study of cTn response to exercise in male and female 
runners who reported no sex-differences (Traiperm et al., 2012). It is entirely possible 
that the divergent results are influenced, at least in part, by the lack of control over 
training experience and age in the Traiperm study that have been reported in a range of 
studies (Nie et al., 2011a) (Tian et al., 2012) (Mehta et al., 2012) (Sahlen et al., 2009). 
The apparent role that sex had in mediating the peak response, as well as the percentage 
of subjects with values exceeding the AMI cut-off for cTnT, support the concept that 
there may be sex-related differences in cardio-protection during stress and clinical 
scenarios (Schwarzenberger et al., 2003).  
It is worth noting that we used the third-generation cTnT assay, but not the latest 
fourth-generation high-sensitivity assay. Using the high-sensitivity cTnT assay, 
Sribhen et al. reported that male adolescents have a higher resting cTnT concentration 
than female adolescents (Sribhen et al., 2010). Our current Pre-ex data did not confirm 
this finding. The fact that resting cTnT in most subjects (32/38) was below the detection 
limit of the assay suggests that the relatively low-sensitivity assay used in our study 
might, at least in part, explain the discrepancy. This is a limitation in the present study 
and warrants further investigation. Nonetheless, corresponding with our research goal, 
the prominent response of post-exercise cTnT and the statistically significant sex 
differences observed in the current study indicate that the use of the high-sensitivity 
assay may not substantially alter the key results. 
The mechanism(s) responsible for the lower levels of cTnT observed in young 
female athletes after endurance exercise cannot be directly determined from the current 
observational, cross-sectional design. Some researchers have speculated a role for sex 
hormones to explain the sex-differences in resting cTnT concentration (Sribhen et al., 
2010). Though we did not determine the sex hormone levels it is entirely likely that due 
to the subjects biological age and sexual maturity that there are substantial differences 
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in estrogen level between males and females (Mendelsohn and Karas 1999). In fact, it 
has long been known that the estrogen may exert protective effects on the myocardium 
(Mendelsohn and Karas 1999). Estrogen is thought to have a high antioxidant capacity 
and as such may have the ability to scavenge free radicals and stimulate the expression 
and activities of certain antioxidant enzymes, thereby limiting the oxidative damage of 
cardiomyocytes exposed to conditions of stress or injury (Mendelsohn and Karas 1999). 
Interestingly, our laboratory’s recent animal study showed a temporal association 
between elevations of serum cTnT and myocardial oxidative stress after prolonged 
exercise (Nie et al., 2010). Alternatively it has been speculated that sex-differences in 
resting cTnT were as a consequence of the heart mass of men being larger than women, 
although no empirical study has specifically addressed this (Sribhen et al., 2010). In the 
present study, male runners had greater cardiac diameters, thicknesses and mass than 
the female runners. This is in line with previous investigation about gender differences 
in heart growth, in which showed similar between-sex physiological left ventricular 
differences in this age (de Simone et al., 1995). No significant correlations were 
observed between post-exercise cTnT levels and these cardiac echocardiographic 
variables in the current study. Our findings do not support a role for heart mass in cTn 
release with exercise.  
 
 
Exercise-induced cTnT release  
We observed that all athletes demonstrated an increase in cTnT, while 79% of our 
subjects exceeded the AMI clinical cut-off value. This is at odds with previous work 
employing a simple pre-/post-exercise design (Shave et al., 2007) but confirms an 
elegant study using multiple time measurements (Middleton et al., 2008). It is worth 
noting that the total myocardial work undertaken was low in the present study (21 km 
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run, ~1.5 h duration) when compared to previous studies that have employed endurance 
tasks over many hours, days and even weeks (Shave et al., 2007). Given that a higher 
cardiac load likely results in a larger cTnT release (Fu et al., 2009), the magnitude of 
the release of cTnT in the current study was pronounced. The prominent response in 
cTnT release may be partly attributed to the appropriate time point of post-exercise 
cTnT measurement based on our previous work (Nie et al., 2011a) (Tian et al., 2012)  
In addition, the prominent cTnT response in the current study may also be related to the 
unique participant group: adolescent runners. Our recent lab-based study showed that 
the magnitude of exercise-induced release of cTnT may be more pronounced in the 
immature hearts of adolescents (Tian et al., 2012).  
 
Implications 
The fact that all subjects in the current study had elevated cTnT post-exercise suggests 
that this is likely a normal, physiological response. Further, all runners continued their 
routine training and long-distance run races for >1 year after the experiment, and none 
had any clinical symptoms indicative of cardiac events over this period.  
It has been suggested that the use of the general population as a “reference” 
might not be appropriate for athletes being evaluated for medical conditions using 
biomarkers such as cTn (Kratz et al., 2002). This has prompted some to suggest that 
cTn values might be stratified according to the physical activity of the subjects to 
improve the clinical usefulness of the biomarker (Lippi and Banfi, 2010). Our work 
extends this to sex-related differences. Our findings highlight the importance of 
interpreting the post-exercise cTn levels in a sex-specific manner. Recent reports 
suggest that women’s involvement in endurance training and competitive events is 
increasing (Hoffman et al., 2010), so the relationship between cTn release and sports 
in both genders will require further scrutiny.  
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Limitations and future research 
Several limitations should be considered. The first important limitation is that the 
women were evaluated regardless of their menstrual cycle phase, which could influence 
blood estrogen concentration and, consequently, post-exercise cTnT release. Further, 
we also did not determine blood estrogen levels. Nevertheless, studies in reproductive 
endocrinology have shown that even in the low-estrogen menstrual phase (i.e. mid-
follicular phase), the blood estrogenic concentration in women is substantially higher 
than that in men (Mendelsohn and Karas 1999). This does promote the idea that 
experimentally examining women at different points in their menstrual cycle, in future 
studies, may be insightful. In addition, all subjects in the present study were familiar 
with the 21 km run with “all-out” effort, which was always used in their routine training. 
Therefore, we are confident that males and females were at very close in terms of effort 
for the 21 km run. Due to the lack of VO2max and in-exercise cardiorespiratory data it is 
not known whether males and females presented with equivalent HR or BP during the 
exercise test.  
 
Conclusion 
Endurance running for 21 km with “all-out” effort led to significantly higher levels of 
cTnT in young males than in training-experience, biological age and sexual-maturity-
matched young female runners. Further, we observed that all athletes demonstrated an 
increase in cTnT, with 79% presenting with an elevated cTnT level above the AMI 
clinical cut-off value. 
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Table 1. Basline parameters among subjects (mean±SD).  
 
 
All  
(n=38) 
Males 
(n=19) 
Females 
(n=19) 
Age (yr) 16.0±1.3 16.1 ± 1.2 15.9 ± 1.4 
Height (cm) 171.9±6.4 175.0 ± 6.1 168.8 ± 5.2* 
Weight (kg) 57.3±8.3 61.6 ± 8.2 52.9 ± 5.9* 
BMI (kg.m-2) 19.3±2.0 20.1 ± 2.0 18.6 ± 1.7* 
Tanner stage 3.8±0.5 3.7 ± 0.6 4.0 ± 0.4 
Training years (yr) 2.2±1.0 2.3 ± 1.0 2.2 ± 1.0 
Training volume (km.wk-1) 65.1±29.6 68.9 ± 26.3 61.2 ± 23.0 
21 km run time (min) 87.8±9.8 81.7 ± 6.5 93.8 ± 8.7* 
* Significantly different from corresponding males value, P<0.05 
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Table 2. Serum cardiac troponin T (cTnT) in male (n=19) and female (n=19) young runners before (Pre-
ex) and after (Post-ex) a 21 km run.  
 
 Pre-ex Post-ex 
All subjects (n=38) 
  
  Median (Range) (ng.l-1) 5 (5-20) 115 (10-1360)* 
  95% confidence interval (ng.l-1) 5-8 155-382 
Positive Rate 1 (95% confidence interval) (%) 10.5 (4.2-24.1) 97.4 (86.5-99.5) 
  Positive Rate 2 (95% confidence interval) (%) 0 (0-9.2) 79.0 (63.7-89.9)* 
Males (n=19) 
  
  Median (Range) (ng.l-1) 5 (5-20) 210 (20-1360)* 
  95% confidence interval (ng.l-1) 5-9 174-594 
Positive Rate 1 (95% confidence interval) (%) 10.5 (2.9-31.4) 100.0 (83.2-100.0) 
  Positive Rate 2 (95% confidence interval) (%) 0 (0-16.8) 94.7 (75.4-99.1)* 
Females (n=19) 
  
  Median (Range) (ng.l-1) 5 (5-20) 80 (10-550)* † 
95% confidence interval (ng.l-1) 4-9 74-233 
Positive Rate 1 (95% confidence interval) (%) 10.5 (2.9-31.4) 94.7 (75.4-99.1) 
  Positive Rate 2 (95% confidence interval) (%) 0 (0-16.8) 63.2 (41.0-80.9)* † 
* Significantly different from corresponding Pre-ex value, P<0.05 
† Significantly different from corresponding males value, P<0.05 
Positive Rate 1: Percentage of subjects with cTnT exceeding the 99th percentile value of 10 ng.l-1 
Positive Rate 2: Percentage of subjects with cTnT exceeding the acute myocardial infarction cut-off of 
50 ng.l-1 
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Table 3. Basic echocardiographic data in male (n=19) and female (n=19) young runners are shown 
(mean ±SD) 
 
All subjects (n=38) Males (n=19) Females (n=19) 
IVSd (mm) 9.6±1.6 10.1±1.9 9.0±1.1 
LVIDd (mm) 48.0±4.4 51.3±2.2 44.8±3.5* 
LVPWd (mm) 10.1±1.7 10.8±1.7 9.4±1.4* 
LVEDV (ml) 110.5±24.0 128.5±14.3 92.5±17.2* 
LV mass (g) 170.8±51.9 204±48 138±30* 
LV mass index (g.BSA-1) 102.6±26.0 117±25 87.7±17.5* 
EF (%) 60.5±5.7 60.5±3.3 60.6±7.5 
IVSd, interventricular septal end diastolic dimension; LVIDd, left ventricular internal diameter at 
end diastole; LVPWd, left ventricular posterior free wall at end diastole; LVEDV, end-diastolic left 
ventricular volume; LV mass, left ventricular mass; EF, ejection fraction; BSA, body surface area  
* Significantly different from corresponding males value, P<0.05 
 
